相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antihelminthic Niclosamide Induces Autophagy and Delayed Apoptosis in Human Non-small Lung Cancer Cells In Vitro and In Vivo
Woei-Horng Chai et al.
ANTICANCER RESEARCH (2020)
Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses
C. E. Hulseberg et al.
JOURNAL OF VIROLOGY (2019)
Myricanol rescues dexamethasone-induced muscle dysfunction via a sirtuin 1-dependent mechanism
Shengnan Shen et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
A novel strategy for treatment of cancer cachexia targeting xanthine oxidase in the brain
Miaki Uzu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)
Nanoliposomal Encapsulation Enhances In Vivo Anti-Tumor Activity of Niclosamide against Melanoma
Mahdi Hatamipour et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)
Drug repurposing to overcome resistance to various therapies for colorectal cancer
Winnie Fong et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Metastasis and cachexia: alongside in clinics, but not so in animal models
Rebeka Tomasin et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer
Fan Luo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway
Yongxia Zhu et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Pharmacological Interventions for Treatment of Sarcopenia: Current Status of Drug Development for Sarcopenia
Ju Yeon Kwak et al.
ANNALS OF GERIATRIC MEDICINE AND RESEARCH (2019)
STAT3 in Skeletal Muscle Function and Disorders
Eleonora Guadagnin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Physostigmine-loaded liposomes for extended prophylaxis against nerve agent poisoning
Ju-Hwan Park et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
miR-29b contributes to multiple types of muscle atrophy
Jin Li et al.
NATURE COMMUNICATIONS (2017)
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice
Francesca Molinari et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
mTOR as a Key Regulator in Maintaining Skeletal Muscle Mass
Mee-Sup Yoon
FRONTIERS IN PHYSIOLOGY (2017)
Niclosamide: Beyond an antihelminthic drug
Wei Chen et al.
CELLULAR SIGNALLING (2017)
Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line
Benxu Cheng et al.
PLOS ONE (2017)
Skeletal muscle regeneration and impact of aging and nutrition
Carla Domingues-Faria et al.
AGEING RESEARCH REVIEWS (2016)
STAT3 in the systemic inflammation of cancer cachexia
Teresa A. Zimmers et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Rebecca C. Arend et al.
ONCOTARGET (2016)
Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling
Xiangzheng Chen et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
SIRT1 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the Oxidative Stress and p38MAPK Pathways
Yang Ruan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Significantly enhanced bioavailability of niclosamide through submicron lipid emulsions with or without PEG-lipid: a comparative study
Xingwang Zhang et al.
JOURNAL OF MICROENCAPSULATION (2015)
WNT/β-Catenin Signaling Regulates Multiple Steps of Myogenesis by Regulating Step-Specific Targets
Akiko Suzuki et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Mitochondria, Muscle Health, and Exercise with Advancing Age
Heather N. Carter et al.
PHYSIOLOGY (2015)
Nutritional Supplements in Support of Resistance Exercise to Counter Age-Related Sarcopenia
Stuart M. Phillips
ADVANCES IN NUTRITION (2015)
Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
Rajmohan Rajamuthiah et al.
PLOS ONE (2015)
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Sue C. Bodine et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice
Hanlin Tao et al.
NATURE MEDICINE (2014)
The intriguing regulators of muscle mass in sarcopenia and muscular dystrophy
Kunihiro Sakuma et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Stat3 Activation Links a C/EBPδ to Myostatin Pathway to Stimulate Loss of Muscle Mass
Liping Zhang et al.
CELL METABOLISM (2013)
Cellular and molecular mechanisms of muscle atrophy
Paolo Bonaldo et al.
DISEASE MODELS & MECHANISMS (2013)
Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer
Rui Li et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Discovery of O-Alkylamino-Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents
Haijun Chen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Reawakening Atlas: Chemical Approaches To Repair or Replace Dysfunctional Musculature
Da-Woon Jung et al.
ACS CHEMICAL BIOLOGY (2012)
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia
Andrea Bonetto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Structure-Activity Analysis of Niclosamide Reveals Potential Role for Cytoplasmic pH in Control of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling
Bruno D. Fonseca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Molecular and cellular mechanisms of skeletal muscle atrophy: an update
Alessandro Fanzani et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2012)
Niclosamide induces mitochondria fragmentation and promotes both apoptotic and autophagic cell death
So Jung Park et al.
BMB REPORTS (2011)
Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations
Takuya Osada et al.
CANCER RESEARCH (2011)
A Method for the Direct Identification of Differentiating Muscle Cells by a Fluorescent Mitochondrial Dye
Tetsuaki Miyake et al.
PLOS ONE (2011)
Losartan Restores Skeletal Muscle Remodeling and Protects Against Disuse Atrophy in Sarcopenia
Tyesha N. Burks et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Sarcopenia: European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft et al.
AGE AND AGEING (2010)
Dependence of dexamethasone-induced Akt/FOXO1 signaling, upregulation of MAFbx, and protein catabolism upon the glucocorticoid receptor
Weidong Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-α and angiotensin II by β-hydroxy-β-methylbutyrate
Helen L. Eley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
NF-κB-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release
S Di Marco et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The IGF-1/PI3K/Akt pathway prevents short article expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors
TN Stitt et al.
MOLECULAR CELL (2004)
Cancer cachexia
KCH Fearon et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2002)
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
MD Gomes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
